Quantbot Technologies LP Pulmonx Corp Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.77 - $9.82 $44,527 - $75,780	7,717 New	7,717 $48,000
Q4 2023 Feb 14, 2024	BUY	$7.89 - $13.14 $52,784 - $87,906	6,690 Added 2524.53%	6,955 $88,000
Q3 2023 Nov 07, 2023	BUY	$9.88 - $14.0 $128 - $182	13 Added 5.16%	265 $2,000
Q2 2023 Aug 08, 2023	SELL	$10.78 - $13.65 $366,951 - $464,646	-34,040 Reduced 99.27%	252 $3,000
Q1 2023 May 12, 2023	BUY	$7.49 - $12.54 $256,847 - $430,021	34,292 New	34,292 $383,000
Q2 2022 Aug 09, 2022	BUY	$14.0 - $27.95 $421,176 - $840,847	30,084 New	30,084 $442,000
Q4 2021 Feb 11, 2022	SELL	$29.72 - $45.1 $44,609 - $67,695	-1,501 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$35.98 - $44.48 $399,054 - $493,327	-11,091 Reduced 88.08%	1,501 $54,000
Q2 2021 Aug 12, 2021	BUY	$37.61 - $48.0 $473,585 - $604,416	12,592 New	12,592 $555,000
Q1 2021 May 14, 2021	SELL	$44.0 - $67.54 $39,600 - $60,786	-900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $35,379 - $62,118	900 New	900 $62,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.